fda status of bpc-157 and tb-500 Staff: No Compounding for BPC-157, TB-500, 5 More FDA Puts BPC-157, TB-500, and
Description
99% purity confirmed via HPLC on qualifying batches

Quinn E, Kuzawa C

This does not change the dose, just the injection experience

The compound's natural origin in protective gastric secretions aligns with its documented tissue-protective and healing-promoting properties
Biohacker Protocol (experimental) Dose: 0.25 mg (= 10 clicks) Duration: Continuous Frequency: Twice daily Cycle Interval: No fixed interval / take 1 week off every 8 weeks Goal / Description: Micro-dosing approach focusing on steady fat metabolism
